Intervention Review

Tamoxifen for hepatocellular carcinoma

  1. Anna K Nowak1,
  2. Michael Findlay2,
  3. Gordana Culjak3,
  4. Martin R Stockler4,*

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 19 JUL 2004

Assessed as up-to-date: 23 MAY 2004

DOI: 10.1002/14651858.CD001024.pub2

How to Cite

Nowak AK, Findlay M, Culjak G, Stockler MR. Tamoxifen for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001024. DOI: 10.1002/14651858.CD001024.pub2.

Author Information

  1. 1

    Sir Charles Gardiner Hospital and University of Western Australia, Department of Medical Oncology, Perth, WA, Australia

  2. 2

    Wellington Hospital, Medical Oncology, Wellington South, New Zealand

  3. 3

    Faculty of Information Technology, Department of Information Systemes, Sydney, NSW, Australia

  4. 4

    University of Sydney, NHMRC Clinical Trials Centre and Sydney Cancer Centre, Camperdown, NSW, Australia

*Martin R Stockler, NHMRC Clinical Trials Centre and Sydney Cancer Centre, University of Sydney, GH6 RPAH, Missenden Road, Camperdown, NSW, 2050, Australia.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JUL 2004


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.